Abstract:Intestinal inflammatory disorders, such as inflammatory bowel disease (IBD), are associated with increased pro-inflammatory cytokine secretion in the intestines. Furthermore, intestinal inflammation increases the risk of enteric cancer, which is a common malignancy globally. Native anti-inflammatory peptides are a class of anti-inflammatory agents that could be used in the treatment of several intestinal inflammation conditions. However, potential cytotoxicity, and poor anti-inflammatory activity have prevented their development as anti-inflammatory agents. Therefore, in this study, we designed and developed a novel hybrid peptide for the treatment of intestinal inflammation. Eight hybrid peptides were designed by combining the active centers of antimicrobial peptides, including LL-37 (13-36), YW12D, innate defense regulator 1, and cathelicidin 2 (1-13) with thymopentin or the active center of thymosin alpha 1 (Tα1) (17-24). The hybrid peptide, LL-37-Tα1 (LTA), had improved anti-inflammatory activity with minimal cytotoxicity. LTA was screened by molecule docking and in vitro experiments. Likewise, its anti-inflammatory effects and mechanisms were also evaluated using a lipopolysaccharide (LPS)-induced intestinal inflammation murine model. The results showed that LTA prevented LPS-induced impairment in the jejunum epithelium tissues and infiltration of leukocytes, which are both histological markers of inflammation. Additionally, LTA decreased the levels of tumor necrosis factor-alpha, interferon-gamma, interleukin-6, and interleukin-1β. LTA increased the expression of zonula occludens-1 and occludin, and reduced permeability and apoptosis in the jejunum of LPS-treated mice. Additionally, its anti-inflammatory effect is associated with neutralizing LPS, binding to the Toll-like receptor 4-myeloid differentiation factor 2 (TLR4/MD-2) complex, and modulating the nuclear factor-kappa B signal transduction pathway. The findings of this study suggest that LTA may be an effective therapeutic agent in the treatment of intestinal inflammation.

Novel Pentapeptide Derived from Chicken By-Product Ameliorates DSS-Induced Colitis by Enhancing Intestinal Barrier Function Via AhR-Induced Src Inactivation

FSGHF3 and Peptides, Prepared from Fish Skin Gelatin, Exert a Protective Effect on DSS-induced Colitis Via the Nrf2 Pathway

Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin

Protective effect of walnut active peptide against dextran sulfate sodium-induced colitis in mice based on untargeted metabolomics

Preventive and synbiotic effects of the soluble dietary fiber obtained from <i>Lentinula edodes</i> byproducts and <i>Lactobacillus plantarum</i> LP90 against dextran sulfate sodium-induced colitis in mice

Protective Effect of Gallus gallus domesticlus Brisson Peptides on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice

A Novel Peptide Ameliorates LPS-Induced Intestinal Inflammation and Mucosal Barrier Damage via Its Antioxidant and Antiendotoxin Effects

Bacillus Amyloliquefaciens SC06 Relieving Intestinal Inflammation by Modulating Intestinal Stem Cells Proliferation and Differentiation Via AhR/STAT3 Pathway in LPS-Challenged Piglets

Design and Development of a Novel Peptide for Treating Intestinal Inflammation

Potential Mechanisms Mediating the Protective Effects of Tricholoma matsutake-Derived Peptides in Mitigating DSS-Induced Colitis

Rice Protein Peptides Alleviate Dextran Sulfate Sodium-Induced Colitis Via the Keap1-Nrf2 Signaling Pathway and Regulating Gut Microbiota.

Lactiplantibacillus Plantarum NMGL2 Exopolysaccharide Ameliorates DSS-induced IBD in Mice Mainly by Regulation of Intestinal Tight Junction and NF-κB P65 Protein Expression

Tilapia Skin Peptides, a By-Product of Fish Processing, Ameliorate DSS-induced Colitis by Regulating Inflammation and Inhibiting Apoptosis

Isolation and Identification of Peptides from Simulated Gastrointestinal Digestion of Preserved Egg White and Their Anti-Inflammatory Activity in TNF-α-induced Caco-2 Cells.

In Vivo and in Silico Studies on the Mechanisms of Egg White Peptides in Relieving Acute Colitis Symptoms.

Lycopene Ameliorated DSS-Induced Colitis by Improving Epithelial Barrier Functions and Inhibiting the Escherichia Coli Adhesion in Mice

Wheat peptide alleviates DSS-induced colitis by activating the Keap1-Nrf2 signaling pathway and maintaining the integrity of the gut barrier

Galli Gigeriae Endothelium Corneum: Its Intestinal Barrier Protective Activity in Vitro and Chemical Composition

Egg White Peptides Ameliorate Dextran Sulfate Sodium-Induced Acute Colitis Symptoms by Inhibiting the Production of Pro-Inflammatory Cytokines and Modulation of Gut Microbiota Composition.

Ginseng Polysaccharides and its Effective Subfraction Protects Against Dextran Sodium Sulfate-Induced Colitis via Regulating NF-κB Signaling Pathway, Recovering Intestinal Barrier and Adjusting Gut Microbiota

Sea Cucumber Peptides Ameliorate DSS-Induced Ulcerative Colitis: the Role of the Gut Microbiota, the Intestinal Barrier, and Macrophage Polarization